A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

NCT02715115 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: NNZ-2566
DRUG: Placebo

Sponsor

Neuren Pharmaceuticals Limited

Collaborators

[object Object]